Liberum Capital restated their buy rating on shares of Udg Healthcare (LON:UDG) in a research report sent to investors on Tuesday.

UDG has been the topic of several other research reports. Numis Securities reaffirmed a hold rating and issued a GBX 660 ($8.62) price target on shares of Udg Healthcare in a report on Tuesday, November 27th. Peel Hunt reaffirmed a buy rating on shares of Udg Healthcare in a report on Wednesday, October 3rd. Barclays reaffirmed an equal weight rating on shares of Udg Healthcare in a report on Friday, September 28th. Royal Bank of Canada initiated coverage on Udg Healthcare in a report on Wednesday, November 7th. They issued an outperform rating and a GBX 800 ($10.45) price target on the stock. Finally, Jefferies Financial Group lowered their price target on Udg Healthcare from GBX 890 ($11.63) to GBX 765 ($10.00) and set a buy rating on the stock in a report on Friday, December 14th. Five investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Udg Healthcare has a consensus rating of Hold and an average price target of GBX 812.89 ($10.62).

Shares of LON UDG opened at GBX 578 ($7.55) on Tuesday. Udg Healthcare has a 52 week low of GBX 690 ($9.02) and a 52 week high of GBX 963 ($12.58).

The firm also recently declared a dividend, which will be paid on Monday, February 4th. Shareholders of record on Thursday, January 10th will be issued a $0.12 dividend. The ex-dividend date of this dividend is Thursday, January 10th. This represents a dividend yield of 1.55%. This is a boost from Udg Healthcare’s previous dividend of $0.04.

In related news, insider Myles Lee sold 6,000 shares of the firm’s stock in a transaction dated Tuesday, November 27th. The stock was sold at an average price of GBX 590 ($7.71), for a total transaction of £35,400 ($46,256.37).

Udg Healthcare Company Profile

UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services.

Featured Story: Purposes and Functions of the Federal Reserve

Analyst Recommendations for Udg Healthcare (LON:UDG)

Receive News & Ratings for Udg Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare and related companies with's FREE daily email newsletter.